Verquvo - (2.5 mg ; Tablet)

Generic Name	Vericiguat	Innovator	MSD
Dosage	2.5 mg ; Tablet	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	VERQUVO is a soluble guanylate cyclase (sGC) stimulator, indicated to reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less than 45%.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
*******	*** \ *********	*** **, ****	*******	****	*** ****** *** ****
********* ******	*** \ *********	*** **, ****	*******	****	*** ****** *** ****
****	*** \ *********	*** **, ****	*******	****	*** ****** *** ****

Chronology Of Events

Verquvo - (5 and 10 mg ; Tablet)

Generic Name	Vericiguat	Innovator	MSD
Dosage	5 and 10 mg ; Tablet	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	VERQUVO is a soluble guanylate cyclase (sGC) stimulator, indicated to reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less than 45%.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
********* ******	*** \ *********	*** **, ****	*******	****	*** ****** *** ****
****	*** \ *********	*** **, ****	*******	****	*** ****** *** ****
*** ****	*** \ *********	*** **, ****	*******	****	*** ****** *** ****

Chronology Of Events